• 10058-F4: A Next-Gen Small-Molecule c-Myc Inhibitor in Ap...

  2025-10-23

  10058-F4 stands out as a cell-permeable c-Myc-Max dimerization inhibitor, empowering researchers to dissect oncogenic transcription and mitochondrial apoptosis with high specificity. Its proven efficacy in acute myeloid leukemia and prostate cancer xenograft models, combined with actionable workflow optimizations, makes it an essential tool for advanced apoptosis assays and telomerase regulation studies.

• 10058-F4: Small-Molecule c-Myc Inhibitor for Apoptosis As...

  2025-10-22

  10058-F4 redefines precision in apoptosis and cancer pathway research as a cell-permeable c-Myc-Max dimerization inhibitor. Its unique mechanism—disrupting c-Myc/Max heterodimers—enables advanced functional studies in acute myeloid leukemia, prostate cancer, and telomerase regulation. Unlock robust, reproducible workflows and actionable troubleshooting strategies for your next-generation oncology experiments.

• 10058-F4: Unlocking c-Myc-Max Dimerization Inhibition for...

  2025-10-21

  Explore how the small-molecule c-Myc-Max dimerization inhibitor 10058-F4 advances apoptosis assay development and telomerase regulation research. This article uniquely bridges mitochondrial apoptosis, TERT expression, and stem cell biology for translational oncology.

• 10058-F4: Advancing c-Myc-Max Inhibition for Targeted Apo...

  2025-10-20

  Explore how 10058-F4, a cell-permeable c-Myc-Max dimerization inhibitor, uniquely enables targeted apoptosis assays and advanced research into stem cell telomerase regulation. This article delves deeper into mechanistic crosstalk between oncogenic pathways and DNA repair than previous reviews.

• 10058-F4: Advanced c-Myc-Max Dimerization Inhibitor for A...

  2025-10-19

  10058-F4 is a potent, cell-permeable c-Myc-Max dimerization inhibitor, enabling targeted disruption of oncogenic transcriptional programs and mitochondrial apoptosis. This guide details optimized workflows, advanced applications in leukemia and prostate cancer models, and troubleshooting strategies for maximizing research impact.

• Beyond the Bench: Harnessing c-Myc Tag Peptide for Next-G...

  2025-10-18

  This thought-leadership article bridges mechanistic depth and actionable strategy for translational researchers. It explores how the c-Myc tag Peptide (A6003) is revolutionizing the dissection of transcription factor dynamics, immunoassays, and proto-oncogene c-Myc biology—expanding relevance to cancer research and immune signaling. By integrating evidence from cutting-edge autophagy research and benchmarking innovations, this resource offers a visionary pathway for leveraging synthetic c-Myc peptides in high-impact translational workflows.

• Chloroquine: Autophagy Inhibitor for Advanced Research Wo...

  2025-10-17

  Chloroquine, a dual autophagy and Toll-like receptor inhibitor, empowers malaria and rheumatoid arthritis research with precision pathway modulation. Discover optimized protocols, troubleshooting strategies, and future-facing applications that set this anti-inflammatory agent apart as a pivotal scientific tool.

• Diclofenac in Translational Inflammation Research: Mechan...

  2025-10-16

  Explore the multifaceted role of Diclofenac, a non-selective COX inhibitor, in human-relevant inflammation and pharmacokinetic research. This in-depth article uniquely analyzes Diclofenac's utility in translational models, bridging molecular action, advanced organoid assays, and the latest stem cell-derived methodologies.

• It has been known that LOX is

  2023-07-06

  

  It has been known that 5-LOX is the rate-limiting enzyme for the products of LTs, and LTs actively participate in the activation of neutrophils [10]. In our study, we determined whether 5-LOX was upregulated in pancreatic tissues during ANP. Moreover, we investigated whether the inhibition of expres

• br Results and discussion br Conclusions

  2023-07-06

  

  Results and discussion Conclusions In this report we present the synthesis, structure determination, and the in vitro and in vivo evaluation of a series of new quinone analogues aiming to find novel lead structures for the development of 5-LO inhibitors. Our findings support that also the hydr

• The identification of novel kinase inhibitor scaffolds

  2023-07-05

  

  The identification of novel kinase inhibitor scaffolds is highly desirable in order to develop selective kinase inhibitors. Small-molecule inhibitors of Interleukin-2-inducible T-cell kinase (Itk) that are based on the 3-aminopyridin-2-one fragment 1 have been reported. Despite derivatisation of 1 y

• The phylogenetic relationship demonstrates that both bovine

  2023-07-05

  

  The phylogenetic relationship demonstrates that both bovine and porcine 12/15-LO is more related to the human enzyme than the rabbit enzyme, despite the fact that the rabbit reticulocyte enzyme is a 15-lipoxygenase. The rabbit is one single species that expresses a 12/15 LO with 15-LO activity while

• risedronic acid mg Furthermore low affinity sites that

  2023-07-05

  

  Furthermore, low-affinity sites that share no structural homology with the aforementioned sites have been described in the transmembrane domain. It has been discovered that, in α1βγ2 receptors, potentiation of GABA-activated currents by high concentrations of diazepam is biphasic, with a high- and a

• br Material and methods br Results

  2023-07-05

  

  Material and methods Results Discussion Didox was originally created asa cytostatic drug to inhibit cancer cell proliferation by antagonizing RNR [11]. When used to target highly proliferative cells, Didox has extensive activity in vitro and in vivo. It has also been employed in clinical st

• It has been proposed that angiotensin II Ang

  2023-07-05

  

  It has been proposed that angiotensin II (Ang II) may upregulate COX-2 expression and the subsequent vasoconstrictor prostanoids production through the activation of AT-1 receptors in vascular smooth muscle cells (Hu et al., 2002). Additionally, this peptide is also able to stimulate the generation

11174 records 4/745 page Previous Next 12345 下5页 Last page